1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with n-heptane in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (n-heptane) | Trials (n-heptane) | Recent Studies (post-2010) (n-heptane) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 647 | 3 | 241 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eguchi, Y; Inoue, K; Kobayashi, S; Kudo, I; Ohno, M; Sato, M | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and n-heptane
| Article | Year |
|---|---|
Molecular design of biologically active compounds based on platelet activating factor (PAF): 7-oxabicyclo[2.2.1]heptane system as a strong antagonist of PAF.
Topics: Drug Design; Heptanes; Platelet Activating Factor; Platelet Aggregation Inhibitors; Structure-Activity Relationship | 1992 |